Edition:
India

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.42USD
26 Apr 2018
Change (% chg)

-- (--)
Prev Close
$1.42
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
29,855
52-wk High
$6.15
52-wk Low
$1.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.175
Sep '17 0.00 -0.907
Jun '17 0.00 -0.504
Mar '17 0.00 -0.376
FY 2016 Dec '16 0.28 -0.678
Sep '16 0.20 -0.862
Jun '16 0.22 -1.005
Mar '16 0.14 -1.042
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 2.00
Earnings (per share)
Quarter Ending Jun-18 1 -0.10 -0.10 -0.10 --
Quarter Ending Sep-18 1 -0.09 -0.09 -0.09 --
Year Ending Dec-18 1 -0.41 -0.41 -0.41 -1.57
Year Ending Dec-19 1 -0.32 -0.32 -0.32 -1.18
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -56.64 -8.04 --
EPS (TTM) % 34.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cyclacel Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.58%
# of Holders: 17
Total Shares Held: 789,069
3 Mo. Net Change: -2,000
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.